References
Staff NP, Grisold A, Grisold W, Windebank AJ. (2017).
Chemotherapy-Induced Peripheral Neuropathy: A Current Review [J].
Ann Neurol, 81(6): 772-781.
Ruggiero A, Trombatore G, Triarico S, Arena R, Ferrara P, Scalzone M,
… Riccardi R. (2013). Platinum compounds in children with cancer:
toxicity and clinical management. Anti‐Cancer Drugs [J]. Anticancer
Drugs, 24: 1007‐1019.
Bano N, Najam R, Qazi F, Mateen A. (2016). Clinical Features of OXA
Induced Hypersensitivity Reactions and Therapeutic Approaches [J].
Asian Pac J Cancer Prev, 17(4): 1637-1641.
Argyriou AA, Cavaletti G, Antonacopoulou A, Genazzani AA, Briani C,
Bruna J, … Kalofonos H. (2013). Voltage‐gated sodium channel
polymorphisms play a pivotal role in the development of OXA‐induced
peripheral neurotoxicity: results from a prospective multicenter study
[J]. Cancer, 119: 3570‐3577.
Argyriou AA, Zolota V, Kyriakopoulou O, Kalofonos HP. (2010). Toxic
peripheral neuropathy associated with commonly used chemotherapeutic
agents [J]. J BUON, 15: 435–446.
Scuteri A, Galimberti A, Ravasi M, Pasini S, Donzelli E, Cavaletti G,
Tredici G. (2010). NGF protects dorsal root ganglion neurons from OXA by
modulating JNK/Sapk and ERK1/2 [J]. Neurosci Lett, 486(3): 141-145.
Descoeur J, Pereira V, Pizzoccaro A, Francois A, Ling B, Maffre V,
… Bourinet E. (2011). OXA-induced cold hypersensitivity is due to
remodelling of ion channel expression in nociceptors [J]. EMBO Mol
Med, 3(5): 266-278.
Nieto FR, Entrena JM, Cendán CM, Pozo ED, Vela JM, Baeyens JM. (2008).
Tetrodotoxin inhibits the development and expression of neuropathic pain
induced by paclitaxel in mice [J]. Pain, 137(3): 520-531.
Avan A, Postma TJ, Ceresa C, Avan A, Cavaletti G, Giovannetti E, Peters
GJ. (2015). Platinum-induced neurotoxicity and preventive strategies:
past, present, and future [J]. Oncologist, 20(4): 411-432.
Carozzi VA, Canta A, Chiorazzi A. (2015). Chemotherapy-induced
peripheral neuropathy: What do we know about mechanisms? [J].
Neurosci Lett, 596: 90-107.
Screnci D, McKeage MJ, Galettis P, Hambley TW, Palmer BD, Baguley BC.
(2000). Relationships between hydrophobicity, reactivity, accumulation
and peripheral nerve toxicity of a series of platinum drugs [J]. Br.
J. Cancer, 82: 966-972.
Hall MD, Okabe M, Shen DW, Liang XJ, Gottesman MM. (2008). The role of
cellular accumulation in determining sensitivity to platinum-based
chemotherapy [J]. Annu Rev Pharmacol Toxicol, 48: 495-535.
Johnson JL, Jun L and Mark JM. (2012). Membrane Transporters as
Determinants of the Pharmacology of Platinum Anticancer Drugs [J].
Current Cancer Drug Targets, 12: 962-986.
Sprowl JA, Ciarimboli G, Lancaster CS, Giovinazzo H, Gibson AA, Du G,
… Sparreboom A. (2013). OXA induced neurotoxicity is dependent on
the organic cation transporter OCT2 [J]. Proc Natl Acad Sci USA,
110: 11199-11204.
Cavaletti G. (2014). Chemotherapy‐induced peripheral neurotoxicity
(CIPN): what we need and what we know [J]. J Peripher Nerv Syst,
19(2): 66-76.
Burger H, Zoumaro DA, Boersma AW, Helleman J, Berns EM, Mathijssen RH,
… Wiemer EA. (2010). Differential transport of platinum compounds
by the human organic cation transporter hOCT2 (hSLC22A2) [J]. Br J
Pharmacol, 159(4): 898-908.
Larson CA, Blair BG, Safaei R, Howell SB. (2009). The role of the
mammalian copper transporter 1 in the cellular accumulation of
platinum-based drugs [J]. Mol Pharmacol, 75(2): 324-330.
Jong NN, Nakanishi T, Liu JJ, Tamai I, McKeage MJ. (2011). OXA transport
mediated by organic cation/carnitine transporters OCTN1 and OCTN2 in
overexpressing human embryonic kidney 293 cells and rat dorsal root
ganglion neurons [J]. J Pharmacol Exp Ther, 338(2): 537-547.
Myint K, Li Y, Paxton J, McKeage M. (2015). Multidrug
Resistance-Associated Protein 2 (MRP2) Mediated Transport of OXA-Derived
Platinum in Membrane Vesicles [J]. PLoS One, 1(10): 7.
Holzer AK, Varki NM, Le QT, Gibson, MA, Naredi P, Howell SB. (2006).
Expression of the human copper influx transporter 1 in normal and
malignant human tissues [J]. J Histochem Cytochem, 54: 1041-1049.
Ciarimboli G. (2014). Membrane transporters as mediators of cisplatin
side-effects [J]. Anticancer Res, 34(1): 547-550.
Bai M, Ma Z, Sun D, Zheng C, Weng Y, Yang X, … Jiang H. (2017).
Multiple drug transporters mediate the placental transport of sulpiride
[J]. Arch Toxicol, 91(12): 3873-3884.
Li L, Weng Y, Wang W, Bai M, Lei H, Zhou H, Jiang H. (2017). Multiple
organic cation transporters contribute to the renal transport of
sulpiride [J]. Biopharm Drug Dispos, 38(9): 526-534.
Ma Z, Yang X, Jiang T, Bai M, Zheng C, Zeng S, … Jiang H. (2017).
Multiple SLC and ABC Transporters Contribute to the Placental Transfer
of Entecavir [J]. Drug Metab Dispos, 45(3): 269-278.
Burkey T, Hingtgen CM, Vasko MR. (2004). Isolation and culture of
sensory neurons from the dorsal-root ganglia of embryonic or adult rats
[J]. Methods Mol Med, 99: 189-202.
Tu M, Li L, Lei H, Ma Z, Chen Z, Sun S, … Jiang H. (2014).
Involvement of Organic Cation Transporter1 and Cytochrome P450 3A4 in
Retrorsine Induced Toxicity [J]. Toxicology, 322: 34-42.
Li LP, Song FF, Weng YY, Yang X, Wang K, Lei HM, … Jiang HD.
(2016). Role of OCT2 and MATE1 in renal disposition and toxicity of
nitidine chloride [J]. Br J Pharmacol, 173(16): 2543-2554.
Burkey TH, Hingtgen CM, Vasko MR. (2004). Isolation and culture of
sensory neurons from the dorsal-root ganglia of embryonic or adult rats
[J]. Methods Mol Med, 99: 189-202.
Ip V, Liu JJ, McKeage MJ. (2013). Evaluation of effects of copper
histidine on copper transporter 1-mediated accumulation of platinum and
oxaliplatin-induced neurotoxicity in vitro and in vivo [J]. Clin Exp
Pharmacol Physiol, 40(6): 371-378.
Ip V, Liu JJ, Mercer JF, McKeage MJ. (2010). Differential expression of
ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue [J].
Mol Pain, 13(6): 53.
Li YQ, Yin JY, Liu ZQ, Li XP. (2008). Copper efflux transporters ATP7A
and ATP7B: Novel biomarkers for platinum drug resistance and targets for
therapy [J]. IUBMB Life, 70(3): 183-191.
Lasorsa A, Nardella MI, Rosato A, Mirabelli V, Caliandro R, Caliandro R,
… Arnesano F. (2019). Mechanistic and Structural Basis for
Inhibition of Copper Trafficking by Platinum Anticancer Drugs [J]. J
Am Chem Soc, 141(30): 12109-12120.
Myint K, Li Y, Paxton J, McKeage M. (2015). Multidrug
Resistance-Associated Protein 2 (MRP2) Mediated Transport of OXA-Derived
Platinum in Membrane Vesicles [J]. PLoS One, 1(10): 7.
Myint K, Biswas R, Li Y, Jong N, Jamieson S, Liu J, … McKeage M.
(2019). Identification of MRP2 as a targetable factor limiting OXA
accumulation and response in gastrointestinal cancer [J]. Sci Rep,
9(1): 2245
Nies AT, Koepsell H, Damme K, Schwab M. (2011). Organic cation
transporters (OCTs, MATEs), in vitro and in vivo evidence for the
importance in drug therapy [J]. Handb Exp Pharmacol, (201): 105-167.
Fujita S, Hirota T, Sakiyama R, Baba M, Ieiri I. (2019). Identification
of drug transporters contributing to OXA-induced peripheral neuropathy
[J]. J Neurochem, 148(3): 373-385.
Zhu Q, Yu L, Qin Z, Chen L, Hu H, Zheng X, Zeng S. (2019). Regulation of
OCT2 transcriptional repression by histone acetylation in renal cell
carcinoma [J]. Epigenetics, 14(8): 791-803.
Chen L, Qin Z, Lei J, Ye S, Zeng K, Wang H, … Yu L. (2019).
Upregulation of miR-489-3p and miR-630 inhibits OXA uptake in renal cell
carcinoma by targeting OCT2 [J]. Acta Pharm Sin B, 9(5): 1008-1020.
Liu YY, Wang TX, Zhou JC, Qu WM, Huang ZL. (2019). Dopamine D1 and D2
receptors mediate analgesic and hypnotic effects of
l-tetrahydropalmatine in a mouse neuropathic pain model [J].
Psychopharmacology (Berl), 236(11): 3169-3182.
Gong X, Yue K, Ma B, Xing J, Gan Y, Wang D, … Li C. (2016).
Levo-tetrahydropalmatine, a natural, mixed dopamine receptor antagonist,
inhibits methamphetamine self-administration and methamphetamine-induced
reinstatement [J]. Pharmacol Biochem Behav, 144: 67-72.
Du Y, Du L, Cao J, Hölscher C, Feng Y, Su H, … Yun KM. (2017).
Levo-tetrahydropalmatine inhibits the acquisition of ketamine-induced
conditioned place preference by regulating the expression of ERK and
CREB phosphorylation in rats [J]. Behav Brain Res, 15(317): 367-373.
Cheng W, Xiang W, Wang S, Xu K. (2019). Tanshinone IIA ameliorates
OXA-induced neurotoxicity via mitochondrial protection and autophagy
promotion [J]. Am J Transl Res. 2019, 11(5): 3140-3149.
Trecarichi A, Flatters SJL. (2019). Mitochondrial dysfunction in the
pathogenesis of chemotherapy-induced peripheral neuropathy [J]. Int
Rev Neurobiol, 145: 83-126.
Toyama S, Shimoyama N, Szeto HH, Schiller PW, Shimoyama M. (2018).
Protective Effect of a Mitochondria-Targeted Peptide against the
Development of Chemotherapy-Induced Peripheral Neuropathy in Mice
[J]. ACS Chem Neurosci, 9(7): 1566-1571.
Lamhonwah AM, Tein I. (2006). Novel localization of OCTN1, an organic
cation/carnitine transporter, to mammalian mitochondria [J]. Biochem
Biophys Res Commun, 345(4): 1315-1325.
Taylor EB. (2017). Functional Properties of the Mitochondrial Carrier
System [J]. Trends Cell Biol, 27(9): 633-644.